UK MHRA To Medtech: Check Before Applying For Non-COVID-19 Trials
Companies may be told to defer submissions
Executive Summary
The UK regulator is expecting a rise in amendments and deviations to ongoing clinical investigations of medical devices due to the COVID-19 pandemic and has issued advice on how companies should manage these.